Synthesis of nitrogen-containing derivatives of 17(20)-pregnenoic, 17β-hydroxypregnanoic, and 17α-hydroxypregnanoic acids as new potential antiandrogens


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

A general scheme for the synthesis of oxazoline and benzoxazole derivatives of [17(20)E]-21-norpregnene differing in the structure of the steroid moiety as well as amides of 17β-hydroxy-3-oxopregn-4-en-21-oic and 17α-hydroxy-3-oxopregn-4-en-21-oic acids was developed. The scheme involved synthesis of the steroid building blocks (appropriately protected derivatives of pregn-17(20)-en-21-oic, 17β-hydroxypregnan-21-oic, and 17α-hydroxypregnan-21-oic acids) and subsequent transformation of these building blocks into the target compounds. Following the developed scheme, synthesis of new nitrogen-containing steroid derivatives exhibiting antiandrogenic activity was enabled.

About the authors

V. A. Zolottsev

V. N. Orekhovich Institute of Biomedical Chemistry of Russian Academy of Sciences

Author for correspondence.
Email: vazolottsev@mail.ru
Russian Federation, 10, Build. 8 ul. Pogodinskaya, Moscow, Russian Federation, 119121

V. A. Kostin

V. N. Orekhovich Institute of Biomedical Chemistry of Russian Academy of Sciences

Email: vazolottsev@mail.ru
Russian Federation, 10, Build. 8 ul. Pogodinskaya, Moscow, Russian Federation, 119121

R. A. Novikov

V. A. Engelhardt Institute of Molecular Biology of Russian Academy of Sciences

Email: vazolottsev@mail.ru
Russian Federation, 32 ul. Vavilova, Moscow, Russian Federation, 119991

Ya. V. Tkachev

V. A. Engelhardt Institute of Molecular Biology of Russian Academy of Sciences

Email: vazolottsev@mail.ru
Russian Federation, 32 ul. Vavilova, Moscow, Russian Federation, 119991

M. G. Zavialova

V. N. Orekhovich Institute of Biomedical Chemistry of Russian Academy of Sciences

Email: vazolottsev@mail.ru
Russian Federation, 10, Build. 8 ul. Pogodinskaya, Moscow, Russian Federation, 119121

M. O. Taratynova

V. N. Orekhovich Institute of Biomedical Chemistry of Russian Academy of Sciences

Email: vazolottsev@mail.ru
Russian Federation, 10, Build. 8 ul. Pogodinskaya, Moscow, Russian Federation, 119121

A. S. Latysheva

V. N. Orekhovich Institute of Biomedical Chemistry of Russian Academy of Sciences

Email: vazolottsev@mail.ru
Russian Federation, 10, Build. 8 ul. Pogodinskaya, Moscow, Russian Federation, 119121

O. V. Zazulina

V. N. Orekhovich Institute of Biomedical Chemistry of Russian Academy of Sciences

Email: vazolottsev@mail.ru
Russian Federation, 10, Build. 8 ul. Pogodinskaya, Moscow, Russian Federation, 119121

V. P. Timofeev

V. A. Engelhardt Institute of Molecular Biology of Russian Academy of Sciences

Email: vazolottsev@mail.ru
Russian Federation, 32 ul. Vavilova, Moscow, Russian Federation, 119991

A. Yu. Misharin

V. N. Orekhovich Institute of Biomedical Chemistry of Russian Academy of Sciences

Email: vazolottsev@mail.ru
Russian Federation, 10, Build. 8 ul. Pogodinskaya, Moscow, Russian Federation, 119121


Copyright (c) 2018 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies